Arterially Delivered Mesenchymal Stem Cells Prevent Obstruction-Induced Renal Fibrosis

Background Mesenchymal stem cells (MSCs) hold promise for the treatment of renal disease. While MSCs have been shown to accelerate recovery and prevent acute renal failure in multiple disease models, the effect of MSC therapy on chronic obstruction-induced renal fibrosis has not previously been eval...

Ausführliche Beschreibung